Newbridge Financial Services Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Newbridge Financial Services Group's BMY Position: Q1 2026 in Review
Newbridge Financial Services Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 470 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #561.
Newbridge Financial Services Group first reported a position in BMY in Q3 2020 and has held it in 22 quarters since. The position peaked at $270K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Newbridge Financial Services Group held 470 shares of Bristol-Myers Squibb worth $28.5K as of Q1 2026.
- Newbridge Financial Services Group left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #561 holding.
- Newbridge Financial Services Group first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 22 quarters since.
- Newbridge Financial Services Group's Bristol-Myers Squibb position peaked at $270K in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.